Click to Share
 

Drug Development Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Drug Discovery: Current Trends in Medicinal Chemistry" on April 26, 2018 at 2:30 PM ET.
12682890
By Project Alive
Vector Production and Active IND Meet Major Milestones in Foundation-Scientists Collaboration to Develop an Experimental Therapy for Young Boys with a Rare Dementia-Like Disease
12680617
By Project Alive
Families Are Making A Cure A Reality for the Rare Disease Hunter Syndrome / MPS II
By Drugshoppe
Drugshoppe's flagship antibiotic program - termed Project TRIPLICO - has recently made a critical step forward.  A lead molecule derivative has shown preliminary antimicrobial activity.
12663171
By SMi Group
"...The U.S. FDA is on track to set a record for orphan drugs approved this year. At last count, 42 orphan drugs have been approved between January 1, 2017 and August 9, 2017.
12648948
By Project Alive
Parent Efforts Bringing Awareness to the Rare Disease Hunter Syndrome / MPS II
By SMi Group
SMi Group releases new interview with Novartis Senior Research Investigator in the lead to 4th Peptides Conference.
12629096
By HOPE BIOSCIENCES, INC.
The staggering cost of cancer treatment means only patients living in the wealthiest countries have access to the latest treatment options against cancer.
By SMi Group
SMi's 4th annual Peptides conference to return in London this summer.
By HOPE BIOSCIENCES, INC.
HOPE BIOSCIENCES, INC. announced today that Dr. Michael Adam has joined the management team to oversee Pharmaceutical and Manufacturing Operations as well as Regulatory Affairs and Quality Assurance. Dr.
12608690
By SMi Group
TissUse joins the speaker lineup for Drug Discovery 2017 in March.
12607315
By SMi Group
SMi Group will once again open its doors to the 11th annual Paediatric Clinical Trials conference taking place on the 20-21 March 2017 in London, UK.
12597830
By Saving Case & Friends, Inc.
Parent-led fundraising efforts have donated over $500,000 to treat the rare disease Hunter Syndrome (MPS II)
By Vivreon Biosciences
Vivreon Biosciences, LLC has been awarded a preclinical drug discovery grant from the Alzheimer's Drug Discovery Foundation (ADDF), a nonprofit organization established in 1998 to provide funding to scientists conducting promising, innovative Alzheimer's.
12585392
By Admescope
New animal facilities for rodent pharmacokinetic studies launched
By SMi Group
SMi Reports (18.08.07.2016): Abeona President & CEO to review opportunities and challenges in orphan drug development at Orphan Drugs & Rare Diseases 2016.
By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has expanded its clinical spray drying capability through the acquisition of a Niro Mobile Minor™ Spray Dryer.
12547768
By Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) announces details for a dinner short course, "Risk Management in Pharmacovigilance - Bridging Clinical Drug Development," to be held at its fifth annual Clinical Trial Innovation Summit.
By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics company, has announced the completion of its first clinical program involving Japanese healthy volunteers.
12536547
By Dr. med. Geza Lakner
Introducing 'Pocketable Clinical Pharmacology', a new mobile knowledge based application for professionals interested in clinical research and drug development, running on Apple iOS mobile devices such as the iPhone, iPad and iPod Touch

All Press Releases

By Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Drug Discovery: Current Trends in Medicinal Chemistry" on April 26, 2018 at 2:30 PM ET.
By Dolomite
Dolomite Microfluidics is simplifying research into drug encapsulation by offering a complete automated system for polymer micro- and nanoparticle generation.
12682890
By Project Alive
Vector Production and Active IND Meet Major Milestones in Foundation-Scientists Collaboration to Develop an Experimental Therapy for Young Boys with a Rare Dementia-Like Disease
12680617
By Project Alive
Families Are Making A Cure A Reality for the Rare Disease Hunter Syndrome / MPS II
By Visiongain
Visiongain's new report Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases,...
By Drugshoppe
Drugshoppe is changing the face of pharmaceutical R&D and contributing to the Houston entrepreneurship community by providing opportunity to graduate students and post docs with its cutting-edge Drug Development Fellowship.
By Drugshoppe
Drugshoppe's flagship antibiotic program - termed Project TRIPLICO - has recently made a critical step forward.  A lead molecule derivative has shown preliminary antimicrobial activity.
12663171
By SMi Group
"...The U.S. FDA is on track to set a record for orphan drugs approved this year. At last count, 42 orphan drugs have been approved between January 1, 2017 and August 9, 2017.
12648948
By Project Alive
Parent Efforts Bringing Awareness to the Rare Disease Hunter Syndrome / MPS II
By Pulmotect, Inc.
Pulmotect, Inc., a clinical-stage biotechnology company developing PUL-042, fast-acting pulmonary immune stimulant for the treatment of antibiotic-resistant respiratory infections, today announced that Mark Benedyk, Ph.D., President and CEO of Telephus...
By SMi Group
SMi Group releases new interview with Novartis Senior Research Investigator in the lead to 4th Peptides Conference.
By Arrowhead Publishers
Arrowhead Publishers is pleased to announce the 11th Annual Pain and Migraine Therapeutics Summit (www.paintherapeuticsummit.com) is coming to San Diego, CA on September 27-28, 2017.
By SMi Group
Leading synthesis expert joins speaker line-up for SMi Group's 4th Peptides Event in July.
12629096
By HOPE BIOSCIENCES, INC.
The staggering cost of cancer treatment means only patients living in the wealthiest countries have access to the latest treatment options against cancer.
By SMi Group
SMi's 4th annual Peptides conference to return in London this summer.
By HOPE BIOSCIENCES, INC.
HOPE BIOSCIENCES, INC. announced today that Dr. Michael Adam has joined the management team to oversee Pharmaceutical and Manufacturing Operations as well as Regulatory Affairs and Quality Assurance. Dr.
12608690
By SMi Group
TissUse joins the speaker lineup for Drug Discovery 2017 in March.
12607315
By SMi Group
SMi Group will once again open its doors to the 11th annual Paediatric Clinical Trials conference taking place on the 20-21 March 2017 in London, UK.
12597830
By Saving Case & Friends, Inc.
Parent-led fundraising efforts have donated over $500,000 to treat the rare disease Hunter Syndrome (MPS II)
By Vivreon Biosciences
Vivreon Biosciences, LLC has been awarded a preclinical drug discovery grant from the Alzheimer's Drug Discovery Foundation (ADDF), a nonprofit organization established in 1998 to provide funding to scientists conducting promising, innovative Alzheimer's.
12585392
By Admescope
New animal facilities for rodent pharmacokinetic studies launched
By SMi Group
SMi Reports (18.08.07.2016): Abeona President & CEO to review opportunities and challenges in orphan drug development at Orphan Drugs & Rare Diseases 2016.
By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, and Upperton, the UK spray drying specialist, have announced a partnership to address drug delivery challenges.
By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has expanded its clinical spray drying capability through the acquisition of a Niro Mobile Minor™ Spray Dryer.
12547768
By Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) announces details for a dinner short course, "Risk Management in Pharmacovigilance - Bridging Clinical Drug Development," to be held at its fifth annual Clinical Trial Innovation Summit.
By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics company, has announced the completion of its first clinical program involving Japanese healthy volunteers.
12536547
By Dr. med. Geza Lakner
Introducing 'Pocketable Clinical Pharmacology', a new mobile knowledge based application for professionals interested in clinical research and drug development, running on Apple iOS mobile devices such as the iPhone, iPad and iPod Touch
12529014
By Admescope
Regulatory compliant package to investigate transporter-mediated drug-drug interactions
12513756
By SMi Group
SMi's 7th annual conference on RNA Therapeutics will aim to deliver an effective scientific toolkit of ideas to implement targeted delivery and mRNA.
By SMi Group
SMi reports: (2015.11.05, Iselin, New Jersey, USA): Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November
12503207
By Saving Case & Friends, Inc.
A rare disease foundation is launching a new initiative to encourage pharmaceutical and biotech companies to engage patients in their pre-clinical research and clinical trial design.

Page: 1 2 Next Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share